West Asia conflict threatens Indian pharma exports with potential INR 5,000 crore hit
Escalating geopolitical tensions in West Asia are beginning to disrupt India’s pharmaceutical export supply chains, with industry estimates warning of potential losses of up to INR 5,000 crore if the situation continues through March.
Engineering | 06/03/2026 | By Darshana
Moderna Inc. Secures Positive CHMP Opinion for First Flu Covid Combination Vaccine
Moderna Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion recommending marketing authorisation for mCOMBRIAX (mRNA-1083) in the European Union.
Engineering | 04/03/2026 | By Darshana
WuXi XDC Grants Exclusive Global License for WuXiTecan-2 Platform in USD 885 Million Pact
WuXi XDC Cayman Inc., a global CRDMO specializing in antibody-drug conjugates (ADCs) and other bioconjugates, has entered into a strategic collaboration with Earendil Labs to advance next-generation ADC development.
Engineering | 03/03/2026 | By Darshana
Indian Scientists Redefine 50-Year-Old Biological Principle
For nearly 50 years, biology has related the story of how bacteria turn their genes on with the help of the so-called “σ (sigma) cycle” – factors that bind RNA polymerase to initiate transcription and then dissociate to allow elongation. This concept was built largely on observations of bacterial strain E. coli σ70.
Engineering | 03/03/2026 | By News Bureau
Mevion Medical Systems Secures CE Mark for MEVION S250-FIT Proton Therapy System
Mevion Medical Systems has received CE Marking under Regulation (EU) 2017/745 (EU MDR) for its MEVION S250-FIT Proton Therapy System, marking a major regulatory milestone for the company.
Engineering | 27/02/2026 | By Darshana | 149
PCI Reopens Portal for Pharmacy Colleges to File SIF by February 27
Pharmacy Council of India has directed existing pharmacy institutions that missed earlier deadlines to submit their Standard Inspection Format (SIF) for the 2026–27 academic session by February 27, after reopening its online portal.
Engineering | 18/02/2026 | By Darshana | 104
Lupin Limited partners with Spektus Pharma to commercialize DeslaFlex in Canada
Lupin Limited has signed a licence and supply agreement with Spektus Pharma to commercialize DeslaFlex, a novel antidepressant, in Canada.
Engineering | 16/02/2026 | By Darshana
Saudi Nod Positions OneSource for Growth in GLP-1 Therapies
OneSource Specialty Pharma Limited has secured approval from the Saudi Food and Drug Authority (SFDA) for its generic version of Ozempic (semaglutide), enabling the company to begin commercialisation in Saudi Arabia through an exclusive partnership with Hikma Pharmaceuticals.
Engineering | 11/02/2026 | By Darshana | 178
New Invivoscribe Platform Targets KMT2A Rearrangements in AML Trials
Invivoscribe, a precision diagnostics company focused on measurable residual disease (MRD) testing, has expanded its oncology portfolio with the launch of the LeukoStrat KMT2A + MRD Assay and Software.
Engineering | 06/02/2026 | By Darshana | 101
India's 2026 Budget Sets Stage for Biopharmaceutical Manufacturing Boom: OPPI
The Organisation of Pharmaceutical Producers of India (OPPI) has described the Union Budget 2026 as a pivotal moment in India’s journey to becoming a global biopharmaceutical manufacturing leader.
Engineering | 02/02/2026 | By Darshana | 151
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy